Companies / BioAtla, Inc.

BioAtla, Inc.

Nasdaq: BCABCIK 1826892SAN DIEGO, CA

Financials · FY2021

Revenue$300.0K
Net income$-59.61M
Total debt
Cash$1.54M
Diluted EPS$-1.01
Shares outstanding1.7M

Ownership

1.7M shares outstanding · as of May 11, 2026
56.9%Insiders
Ownership
Insiders56.86%942,126
Institutions18.98%314,458
Public float24.16%400,342

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Sievers EricChief Medical Officer
36.13%598,705
Vasquez ChristianFormerChief Financial Officer
32.00%530,196
Waldron Richard aFormer Chief Financial Officer
20.73%343,421
Short Jay M PhdCEOFormerChief Executive Officer · Director
3.16%52,294

Institutional holders 4

View all →
HolderValue% of shares
Lido Advisors, LLC$69.0K1.01%
Marshall Wace, LLP$44.4K16.76%
Deutsche Bank AG$43.7K0.64%
BlackRock, Inc.$39.8K0.58%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 28, 2026Short Jay M Phd
CEO
OtherCommon Stock$1.9K-8K
-0.35%
2,229,603
134.56% of shares
low
May 31, 2026Short Jay M Phd
CEO
OtherCommon Stock$1.0K-259
-0.49%
52,294
3.16% of shares
low
Feb 28, 2026Sievers Eric
Executive
OtherCommon Stock$776-3K
-0.87%
358,705
21.65% of shares
low
Feb 28, 2026Waldron Richard a
Executive
OtherCommon Stock$674-3K
-0.79%
343,421
20.73% of shares
low
Feb 28, 2026Vasquez Christian
Executive
OtherCommon Stock$445-2K
-0.62%
290,196
17.51% of shares
low
Mar 12, 2026Short Jay M Phd
CEO
OtherCommon Stock$107-639
-1.20%
52,553
3.17% of shares
low
Mar 10, 2026Vasquez Christian
Executive
GrantCommon Stock$0+240K
+82.70%
530,196
32.00% of shares
low
Mar 10, 2026Sievers Eric
Executive
GrantCommon Stock$0+240K
+66.91%
598,705
36.13% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BCABCommon StockEquity09077B203BBG00Y6GBT61